Company Filing History:
Years Active: 2021-2023
Title: Waracharee Srifa: Innovator in Gene-Corrected Primary Cell Technologies
Introduction
Waracharee Srifa is a prominent inventor based in Stanford, CA (US). He has made significant contributions to the field of gene editing and pharmaceutical compositions, holding a total of 3 patents. His work focuses on innovative methods for gene modification in primary cells, which have the potential to revolutionize treatments for various diseases.
Latest Patents
Waracharee Srifa's latest patents include groundbreaking inventions such as "Pharmaceutical compositions comprising gene-corrected primary cells." This invention provides methods for inducing stable gene modifications via homologous recombination in primary cells, including blood and mesenchymal cells. The patent outlines techniques for enriching genetically modified primary cells with targeted integration at specific nucleic acids. Additionally, it describes methods for preventing or treating diseases by administering genetically modified primary cells or pharmaceutical compositions to affected subjects.
Another notable patent is "Nuclease-mediated genome editing of primary cells." Similar to his previous work, this invention focuses on stable gene modifications in primary cells. It emphasizes the use of DNA nucleases, such as Cas polypeptides, and adeno-associated viral (AAV) vectors to facilitate targeted integration of nucleic acids. This patent also addresses therapeutic applications for preventing or ameliorating diseases through the use of genetically modified cells.
Career Highlights
Waracharee Srifa is affiliated with Leland Stanford Junior University, where he conducts his research and development in gene editing technologies. His innovative work has positioned him as a key figure in the field, contributing to advancements that may lead to new therapeutic options for patients.
Collaborations
Waracharee collaborates with esteemed colleagues, including Daniel P Dever and Rasmus O Bak. These partnerships enhance the research and development of his innovative technologies, fostering a collaborative environment that drives scientific progress.
Conclusion
Waracharee Srifa is a leading inventor in the realm of gene-corrected primary cell technologies. His patents reflect a commitment to advancing medical science and improving patient outcomes through innovative gene editing methods. His contributions are paving the way for future breakthroughs in the treatment of various diseases.